August 14, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced today that it is the newest MedAxiom corporate ...
August 15, 2007 - Thoratec Corp., a world leader in products to treat cardiovascular disease, said today that its PMA (PreMarket Application) seeking approval of its HeartMate II for bridge-to-transplantation will undergo review by an FDA advisory panel later this year.
August 15, 2007 - Merit Medical Systems Inc., a leading manufacturer and marketer of proprietary disposable devices used ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
August 15, 2007 - Performing cardiac CTA after coronary artery bypass surgery (CABG) can reveal unsuspected and ...
August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.
August 14, 2007 - ELA Medical Inc., a Sorin Group company that specializes in the design and manufacture of implantable ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
August 14, 2007 – GlobalMedTek recently announced a revision of its Version 1.0 for its Medical Software Directory ...
August 14, 2007 - High-speed dual-source computed tomography (DSCT) angiography was 95 percent sensitive and 95 percent ...
August 13, 2007 – A study published in the Journal of the American College of Cardiology showed that when AngioJet thrombectomy is used to remove large thrombus before placement of a drug-eluting stent (DES), it is associated with significantly lower rates of subsequent death, repeat heart attack and stent thrombosis.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Aug 13, 2007 - Medtronic Inc. has entered into a definitive agreement with Biophan Technologies Inc. to acquire its MRI ...
August 9, 2007 - Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Mi
Aug. 9, 2007 - Abiomed Inc. today announced financial results for its first quarter of fiscal 2008 with record revenue ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
August 8, 2007 – The FDA gave ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software ...
August 8, 2007 - A U.S. District Court judge enforced a settlement this week between Abbott Laboratories Inc. and Israeli company Medinol Ltd. to removed an entanglement for a key drug-eludting stent heart device Abbott is bringing to the United States.
August 8, 2007 - CircuLite Inc. reported the launch of the clinical development program for its Synergy Pocket ...
August 14, 2007
